The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
The rat brain synucleins; family of proteins transiently associated with neuronal membrane
Abstract
The synuclein cDNA was previously cloned from Torpedo califonica using an antiserum against purified synaptic vesicles. Here we show that this gene hybridizes to several clones in a rat brain cDNA library. These clones represent cDNAs coding for different proteins, thus determining a family. These proteins display similar organization to the Torpedo protein. The homology resides within the repetition of 7 amino acids. The diversity is generated by alternative splicing as suggested by Southern analysis, as well as by sequence analysis. These proteins are specifically expressed in the rat brain. In situ hybridization shows expression of synuclein mRNAs in discrete areas of the brain, the hippocampus is the most intensely stained area. This localization is reminiscent of those molecules involved in phosphoinositols second messenger pathways. Synuclein proteins are present in rat brain in dual form--a small form which is soluble and a large form which is associated with synaptosomal membranes in a regulated fashion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“αSyn is predominantly expressed within the presynaptic terminals of neurons [141–143]”
From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [142]
Citations
Cites
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646
Self-citationCELL-SURFACE ANCHORING OF PROTEINS VIA GLYCOSYL-PHOSPHATIDYLINOSITOL STRUCTURES
Ferguson, M. A. J., & Williams, A. F. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.001441 · Cited by 1,281
Axonal Growth-Associated Proteins
Skene, J. H. P. (1989) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.12.030189.001015 · Cited by 1,145
Houser, C. R., Crawford, G. D., Barber, R. P., Salvaterra, P. M., & Vaughn, J. E. (1983) · Brain Research · doi:10.1016/0006-8993(83)91312-4 · Cited by 748
Noda, M., Takahashi, H. K., Tanabe, T., Toyosato, M., Furutani, Y., Hirose, T., Asai, M., Inayama, S., Miyata, T., & Numa, S. (1982) · Nature · doi:10.1038/299793a0 · Cited by 735
An autoradiographic study of the organization of intrahippocampal association pathways in the rat
Swanson, L. W., Wyss, J. M., & Cowan, W. M. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901810402 · Cited by 704
Protein Import into the Cell Nucleus
Dingwall, C., & Laskey, R. A. (1986) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.02.110186.002055 · Cited by 525
Localization of a family of muscarinic receptor mRNAs in rat brain
Buckley, N. J., Bonner, T. I., & Brann, M. R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-12-04646.1988 · Cited by 478
Research works printed but not linked: 1
- Fuqua, 1989, Induction of the estrogen-regulated 24 K protien by heat shock, Cancer Res., 49, 4127
Cited by
Sorted by citations
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes
Davidson, W. S., Jonas, A., Clayton, D. F., & George, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9443 · Cited by 1,622
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316
Identification of two distinct synucleins from human brain
Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
Chandra, S. S., Gallardo, G., Fernández‐Chacón, R., Schlüter, O. M., & Südhof, T. C. (2005) · Cell · doi:10.1016/j.cell.2005.09.028 · Cited by 990
Bendor, J. T., Logan, T. P., & Edwards, R. H. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.004 · Cited by 825
George, J. M., Jin, H., Woods, W. S., & Clayton, D. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90040-3 · Cited by 844
Clayton, D. F., & George, J. M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01213-7 · Cited by 793
Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
Serpell, L. C., Berriman, J. A., Jakes, R., Goedert, M., & Crowther, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4897 · Cited by 755
α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E. M., Sisk, A., Mallory, M. E., Wong, J., Takenouchi, T., Hashimoto, M., & Masliah, E. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64553-1 · Cited by 737
Tu, P., Galvin, J. E., Baba, M., Giasson, B., Tomita, T., Leight, S., Nakajo, S., Iwatsubo, T., Trojanowski, J. Q., & Lee, V. M. ‐. (1998) · Annals of Neurology · doi:10.1002/ana.410440324 · Cited by 686
Kahle, P. J., Neumann, M., Ozmen, L., Müller, V., Jacobsen, H., Schindzielorz, A., Okochi, M., Leimer, U., van der Putten, H., Probst, A., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06365.2000 · Cited by 642
α-Synuclein Membrane Interactions and Lipid Specificity
Jo, E., McLaurin, J., Yip, C. M., George‐Hyslop, P. S., & Fraser, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004345200 · Cited by 610
The Synucleinopathies: Twenty Years On
Goedert, M., Jakes, R., & Spillantini, M. G. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-179005 · Cited by 590
A Broken α-Helix in Folded α-Synuclein
Chandra, S. S., Chen, X., Rizo, J., Jahn, R., & Südhof, T. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213128200 · Cited by 540
The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy
Spillantini, M. G., & Goedert, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06900.x · Cited by 530
Constitutive Phosphorylation of the Parkinson's Disease Associated α-Synuclein
Okochi, M., Walter, J., Koyama, A., Nakajo, S., Baba, M., Iwatsubo, T., Meijer, L., Kahle, P. J., & Haass, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.390 · Cited by 535
Lin, X. Z., Parisiadou, L., Gu, X., Wang, L., Shim, H., Sun, L., Xie, C., Long, C.-X., Yang, W.-J., Ding, J., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.11.006 · Cited by 532
Maiti, N. C., Apetri, M. M., Zagorski, M. G., CAREY, P. R., & Anderson, V. E. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0356176 · Cited by 524
Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson's Disease Mutation
Jensen, P. H., Nielsen, M. S., Jakes, R., Dotti, C. G., & Goedert, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26292 · Cited by 521
α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesis
Mehra, S., Sahay, S., & Maji, S. K. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.03.001 · Cited by 536
Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases
Mandel, S. A., & Youdim, M. B. H. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.012 · Cited by 453
Larsen, K. E., Schmitz, Y., Troyer, M. D., Mosharov, E. V., Dietrich, P., Quazi, A. Z., Savalle, M., Nemani, V. M., Chaudhry, F. A., Edwards, R. H., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3821-06.2006 · Cited by 424
Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.
Takeda, A., Mallory, M. E., Sundsmo, M. P., Honer, W. G., Hansen, L. A., & Masliah, E. (1998) · Europe PMC (PubMed Central) · Cited by 403
Vila, M., Vukosavić, S., Jackson-Lewis, V. R., Neystat, M., Jakowec, M. W., & Przedborski, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740721.x · Cited by 394
A critical evaluation of the Braak staging scheme for Parkinson's disease
Burke, R. E., Dauer, W. T., & Vonsattel, J. P. (2008) · Annals of Neurology · doi:10.1002/ana.21541 · Cited by 410
The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
Lackie, R. E., Maciejewski, A., Ostapchenko, V. G., Marques-Lopes, J., Choy, W., Duennwald, M. L., Prado, V. F., & Prado, M. A. M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00254 · Cited by 390
α-synuclein in the pathophysiology of Alzheimer’s disease
Twohig, D., & Nielsen, H. M. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0320-x · Cited by 374
Effect of Mutant α-Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line
Lotharius, J., Barg, S., Wiekop, P., Lundberg, C., Raymon, H. K., & Brundin, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205518200 · Cited by 368
Fate of Midbrain Dopaminergic Neurons Controlled by the Engrailed Genes
Simon, H. H., Saueressig, H., Wurst, W., Goulding, M., & O’Leary, D. D. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03126.2001 · Cited by 354
Copper(II)-induced self-oligomerization of α-synuclein
Paik, S. R., Shin, H.-J., Lee, J., Chang, C., & Kim, J. (1999) · Biochemical Journal · doi:10.1042/bj3400821 · Cited by 340
Structural Organization of α-Synuclein Fibrils Studied by Site-directed Spin Labeling
Der-Sarkissian, A., Jao, C. C., Chen, J., & Langen, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305266200 · Cited by 337
The Synuclein FamilyPreprint
Lavedan, C. N. (1998) · Genome Research · doi:10.1101/gr.8.9.871 · Cited by 323
Lipid Binding Inhibits α-Synuclein Fibril Formation
Zhu, M., & Fink, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210136200 · Cited by 321
The physiological role of α‐synuclein and its relationship to Parkinson’s Disease
Sulzer, D., & Edwards, R. H. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14810 · Cited by 320
Song, D. D., Shults, C. W., Sisk, A., Rockenstein, E. M., & Masliah, E. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00342-x · Cited by 301
Han, H., Weinreb, P. H., & Lansbury, P. T. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90071-3 · Cited by 287
Alpha-synuclein and Parkinson's disease
Lücking, C. B., & Brice, A. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000671 · Cited by 289
Neural Activity Controls the Synaptic Accumulation of α-Synuclein
Fortin, D. L., Nemani, V. M., Voglmaier, S. M., Anthony, M. D., Ryan, T. A., & Edwards, R. H. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2922-05.2005 · Cited by 274
YAMADA, M., Iwatsubo, T., Mizuno, Y., & Mochizuki, H. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02728.x · Cited by 278
Hashimoto, M., Hsu, L. J., Sisk, A., Xia, Y., Takeda, A., Sundsmo, M. P., & Masliah, E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00514-9 · Cited by 266
Alpha‐synuclein in Lewy Body Disease and Alzheimer's Disease
Hashimoto, M., & Masliah, E. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00552.x · Cited by 254
α-Synuclein in synaptic function and dysfunction
Sharma, M., & Burré, J. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.11.007 · Cited by 270
Arima, K., Uéda, K., Sunohara, N., Arakawa, K., Hirai, S., Nakamura, M., Tonozuka-Uehara, H., & Kawai, M. (1998) · Acta Neuropathologica · doi:10.1007/s004010050917 · Cited by 239
Kahle, P. J., Neumann, M., Ozmen, L., Müller, V., Odoy, S., Okamoto, N., Jacobsen, H., Iwatsubo, T., Trojanowski, J. Q., Takahashi, H., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63072-6 · Cited by 245
Parkinson’s disease: proteinopathy or lipidopathy?
Fanning, S., Selkoe, D. J., & Dettmer, U. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-019-0103-7 · Cited by 251
Withers, G. S., George, J. M., Banker, G. A., & Clayton, D. F. (1997) · Developmental Brain Research · doi:10.1016/s0165-3806(96)00210-6 · Cited by 235
Meredith, G. E., Totterdell, S., Petroske, E., Cruz, K. S., Callison, R. C., & Lau, Y.-S. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03514-x · Cited by 217
Tong, J., Wong, H., Guttman, M., Ang, L. C., Forno, L. S., Shimadzu, M., Rajput, A. H., Muenter, M. D., Kish, S. J., Hornykiewicz, O., et al. (2009) · Brain · doi:10.1093/brain/awp282 · Cited by 210
α-Synuclein: Normal Function and Role in Neurodegenerative Diseases
Norris, E. H., Giasson, B. I., & Lee, V. M. ‐. (2004) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)60002-0 · Cited by 208
α‐Synuclein produces a long‐lasting increase in neurotransmitter release
Liu, S., Ninan, I., Antonova, I., Battaglia, F., Trinchese, F., Narasanna, A., Kolodilov, N., Dauer, W., Hawkins, R. D., & Arancio, O. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600451 · Cited by 198
The role of α-synuclein in neurodegenerative diseases
Bennett, M. C. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.010 · Cited by 198
SDS-Induced Fibrillation of α-Synuclein: An Alternative Fibrillation Pathway
Giehm, L., Oliveira, C. L. P., Christiansen, G., Pedersen, J. S., & Otzen, D. E. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.060 · Cited by 198
Yu, S., Li, X., Liu, G., Han, J., Zhang, C., Li, Y., Xu, S., Liu, C., Gao, Y., Yang, H., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.028 · Cited by 202
Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?
Mezey, É., Dehejia, A. M., Harta, G., Papp, M. I., Polymeropoulos, M. H., & Brownstein, M. (1998) · Nature Medicine · doi:10.1038/nm0798-755 · Cited by 185
Genes, proteins, and neurotoxins involved in Parkinson’s disease
Halbach, O. V. B. U., Schober, A., & KRIEGLSTEIN, K. G. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.002 · Cited by 180
Identification, localization and characterization of the human γ-synuclein gene
Lavedan, C. N., Leroy, E., Dehejia, A. M., Buchholtz, S. A., Dutra, A., Nussbaum, R. L., & Polymeropoulos, M. H. (1998) · Human Genetics · doi:10.1007/s004390050792 · Cited by 179
Gómez‐Isla, T., Irizarry, M. C., Mariash, A., Cheung, B. S., Soto, O., Schrump, S. E., Sondel, J., Kotilinek, L., Day, J., Schwarzschild, M. A., et al. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00091-x · Cited by 181
Mandel, S. A., Maor, G., & Youdim, M. B. H. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:3:401 · Cited by 171
Synaptic failure and α‐synuclein
Calò, L., Węgrzynowicz, M., Santivañez‐Perez, J., & Spillantini, M. G. (2016) · Movement Disorders · doi:10.1002/mds.26479 · Cited by 179
Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization
Arendt, T. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00516-9 · Cited by 172
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Oliveira, L. M. A., Gasser, T., Edwards, R. H., Zweckstetter, M., Melki, R., Stefanis, L., Lashuel, H. A., Sulzer, D., Vekrellis, K., Halliday, G. M., et al. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00203-9 · Cited by 174
Buchman, V. L., Hunter, H. J. A., Piñón, L. G. P., Thompson, J., Privalova, E. M., Ninkina, N. N., & Davies, A. M. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-22-09335.1998 · Cited by 169
Masliah, E., Iwai, A., Mallory, M. E., Uéda, K., & Saitoh, T. (1996) · Europe PMC (PubMed Central) · Cited by 168
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
Peng, C., Gathagan, R. J., & Lee, V. M. ‐. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.018 · Cited by 173
α-Synuclein–induced Aggregation of Cytoplasmic Vesicles inSaccharomyces cerevisiae
Soper, J. H., Roy, S., Stieber, A., Lee, E., Wilson, R. B., Trojanowski, J. Q., Burd, C. G., & Lee, V. M. ‐. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-08-0827 · Cited by 163
Is Parkinson's disease a primary olfactory disorder?
Hawkes, C. H. (1999) · QJM · doi:10.1093/qjmed/92.8.473 · Cited by 152
Ubiquinone (Coenzyme Q10) and Mitochondria in Oxidative Stress of Parkinson’s Disease
Ebadi, M., Govitrapong, P., Sharma, S., Muralikrishnan, D., Shavali, S., Pellett, L. J., Schafer, R., Albano, C. B., & Eken, J. (2001) · Neurosignals · doi:10.1159/000046889 · Cited by 150
Mori, F., Tanji, K., Yoshimoto, M., Takahashi, H., & Wakabayashi, K. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7929 · Cited by 149
Synphilin-1 is present in Lewy bodies in Parkinson's disease
Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C. A., & Takahashi, H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4 · Cited by 269
Paik, S. R., Lee, J., Kim, D.-H., Chang, C., & Kim, J. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0207 · Cited by 148
Presynaptic Alpha-Synuclein Aggregation in a Mouse Model of Parkinson's Disease
Spinelli, K. J., Taylor, J. K., Osterberg, V. R., Churchill, M. J., Pollock, E., Moore, C., Meshul, C. K., & Unni, V. K. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2581-13.2014 · Cited by 141
Differential localization of α-, β- and γ-synucleins in the rat CNS
Li, J.-Y., Jensen, P. H., & Dahlström, A. B. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00143-4 · Cited by 141
Structural insights on physiological functions and pathological effects of ±‐synuclein
Bisaglia, M., Mammi, S., & Bubacco, L. (2008) · The FASEB Journal · doi:10.1096/fj.08-119784 · Cited by 143
Ahn, B., Rhim, H., Kim, S. Y., Sung, Y., Lee, M., Choi, J., Wolozin, B. L., Chang, J., Lee, Y. H., Kwon, T. K., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110414200 · Cited by 136
Activated Fyn Phosphorylates α-Synuclein at Tyrosine Residue 125
Nakamura, T., Yamashita, H., Takahashi, T., & Nakamura, S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4253 · Cited by 135
Kholodilov, N. G., Neystat, M., Tinmarla, F. O., Steven, E. L., Larsen, K. E., Sulzer, D. L., & Burke, R. E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732586.x · Cited by 133
Cocaine Abusers Have an Overexpression of α-Synuclein in Dopamine Neurons
Mash, D. C., Ouyang, Q., Pablo, J. P., Basile, M. J., Izenwasser, S., LIEBERMAN, A. N., & Perrin, R. J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02564.2003 · Cited by 127
Developmental expression of α-synuclein in rat hippocampus and cerebral cortex
Petersen, K. L., Olesen, O. F., & Mikkelsen, J. D. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00596-x · Cited by 125
α-Synuclein expression is modulated at the translational level by iron
Febbraro, F., Giorgi, M., Caldarola, S., Loreni, F., & Romero‐Ramos, M. (2012) · Neuroreport · doi:10.1097/wnr.0b013e328354a1f0 · Cited by 123
Ribeiro, C. S., Carneiro, K., Ross, C. A., Menezes, J. R. L., & Engelender, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201115200 · Cited by 119
Hashimoto, M., Yoshimoto, M., Sisk, A., Hsu, L. J., Sundsmo, M. P., Kittel, Á., Saitoh, T., Miller, A. L., & Masliah, E. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6978 · Cited by 120
Chapter 6 Molecular and Cellular Biology of Synucleins
Surguchov, A. P. (2008) · International review of cytology · doi:10.1016/s1937-6448(08)01406-8 · Cited by 123
Modeling α-Synuclein Propagation with Preformed Fibril Injections
Chung, H. K., Ho, H.-A., Pérez-Acuña, D., & Lee, S. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.19046 · Cited by 125
Kahle, P. J., Neumann, M., Ozmen, L., & Haass, C. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06902.x · Cited by 115
Calcium-Handling Defects and Neurodegenerative DiseasePreprint
Schrank, S., Barrington, N. M., & Stutzmann, G. E. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a035212 · Cited by 115
The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease
Campion, D., Martin, C., Heilig, R., Charbonnier, F., Moreau, V., Flaman, J., Petit, J., Hannequin, D., Brice, A., & Frébourg, T. (1995) · Genomics · doi:10.1016/0888-7543(95)80208-4 · Cited by 112
Brain neutral lipids mass is increased in α‐synuclein gene‐ablated mice
Barceló‐Coblijn, G., Golovko, M. Y., Weinhofer, I., Berger, J., & Murphy, E. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04348.x · Cited by 109
Polyunsaturated Fatty Acids Induce α-Synuclein-Related Pathogenic Changes in Neuronal Cells
Assayag, K., Yakunin, E., Loeb, V., Selkoe, D. J., & Sharon, R. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070373 · Cited by 109
Vekrellis, K., Rideout, H. J., & Stefanis, L. (2004) · Molecular Neurobiology · doi:10.1385/mn:30:1:001 · Cited by 108
Organization, expression and polymorphism of the human persyn gene
Ninkina, N. N. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.9.1417 · Cited by 107
Wilson, C., Murphy, D. D., Giasson, B. I., Zhang, B., Trojanowski, J. Q., & Lee, V. M. ‐. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403061 · Cited by 108
Imberdis, T., Negri, J. M., Ramalingam, N., Terry-Kantor, E., Ho, G. P. H., Fanning, S., Stirtz, G. L., Kim, T., Levy, O. A., Young‐Pearse, T. L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903216116 · Cited by 102
α-Synuclein pathology as a target in neurodegenerative diseases
Park, H.-J., Kam, T., Dawson, V. L., & Dawson, T. M. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01043-w · Cited by 121
The usual suspects, dopamine and alpha‐synuclein, conspire to cause neurodegeneration
Mor, D. E., Daniels, M. J., & Ischiropoulos, H. (2019) · Movement Disorders · doi:10.1002/mds.27607 · Cited by 107
Mitochondrial Quality Control and Dynamics in Parkinson's Disease
McCoy, M. K., & Cookson, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4019 · Cited by 105
Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein
Jakes, R., Crowther, R. A., Lee, V. M. ‐., Trojanowski, J. Q., Iwatsubo, T., & Goedert, M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00411-5 · Cited by 103
Axonal transport of synucleins is mediated by all rate components
Jensen, P. H., Li, J., Dahlström, A. B., & Dotti, C. G. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00754.x · Cited by 102
Metadata
- Authors
- Maroteaux, L., & Scheller, R. H.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Maroteaux, L.
- ORCID
- Maroteaux, L.
- Venue
- Molecular Brain Research
- Publisher
- Elsevier BV
- Published
- 1991-10
- Volume
- 11
- Issue
- 3-4
- Pages
- 335-343
- ISSN
- 0169-328X (ISSN-L)
- OpenAlex
- W1968390598
- Cited by
- 334
- References
- 29
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 8 · 2023: 7 · 2022: 12 · 2021: 9 · 2020: 14 · 2019: 15 · 2018: 5 · 2017: 9 · 2016: 7 · 2015: 6 · 2014: 6 · 2013: 9 · 2012: 7
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- synuclein, alternative splicing, protein families, hippocampus, synaptosomal membranes, brain-specific expression, rat brain, cDNA cloning
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Brain, DNA, Multigene Family, Molecular Sequence Data, Nerve Tissue Proteins, Oligodeoxyribonucleotides, Organ Specificity, Sequence Homology, Nucleic Acid, Torpedo, Blotting, Northern, Restriction Mapping, Gene Library, Rats, Synucleins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review